Work

Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in moderate-to-severe plaque psoriasis: a phase Ib, randomized, double-blind, placebo-controlled study

Year: 2025

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: British Journal of Dermatology

DOI: 10.1093/bjd/ljaf185

Authors: Jia-Qi Chen, Min Zheng, Wen-Hao Yin, Ping Wang, Xiao-Wei Shi, Tie-Chi Lei, Zhi-Ming Li, Meng Pan, Yu-Ling Shi, Yu-Zhen Li, Congxin Liang, Xiao-Yong Man

Institutions: Second Affiliated Hospital of Zhejiang University, Zhejiang University, First Hospital of Jiaxing, The Affiliated Yongchuan Hospital of Chongqing Medical University, Southern Medical University, Renmin Hospital of Wuhan University, First Affiliated Hospital of Wenzhou Medical University, Shanghai Jiao Tong University, Ruijin Hospital, Second Affiliated Hospital of Harbin Medical University

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410357986

FWCI: 1.185

Cites: 24

Cited by: 4

Related to: 10